Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
This grant aims to support research that advances precision medicine and improves drug safety and effectiveness for pregnant and lactating individuals, fetuses, neonates, and children, including those with disabilities. It focuses on developing new tools and technologies, understanding drug actions and physiological changes during pregnancy and lactation, and creating or improving therapeutic …
Source
Award
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
INCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
National Institutes of Health
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
DoW Toxic Exposures Investigator Initiated Research Award
Dept. of the Army -- USAMRAA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers